No Data
No Data
Leerink Partners Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $463
Elevance Health: Buy Rating Affirmed Amid Favorable Outlook and Strategic Adjustments
UnitedHealth Woes Aren't Dragging Down the Entire Sector. Here's Why. -- Barrons.com
Elevance Health's Preliminary Q1 Earnings Help Ease Market Concerns, Truist Says
Elevance Health Says 1Q Costs In Line With Expectations
CVS, Humana and Elevance Shares Are Trading Lower Thursday: What's Going On?